Gene · 3597
Papers1,963
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,963
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia. | Front Immunol | 2023 | 37600776 | PubTator, text mining | PubMed |
| Complementarity-determining region clustering may cause CAR-T cell dysfunction. | Nat Commun | 2023 | 37563127 | PubTator, text mining | PubMed |
| Hypoxia Primes Human ISCs for Interleukin-Dependent Rescue of Stem Cell Activity. | Cell Mol Gastroenterol Hepatol | 2023 | 37562653 | PubTator, text mining | PubMed |
| SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs. | Virol J | 2023 | 37559103 | PubTator, text mining | PubMed |
| An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma. | Clin Exp Med | 2023 | 37555911 | PubTator, text mining | PubMed |
| Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex. | JID Innov | 2023 | 37554517 | PubTator, text mining | PubMed |
| Efficacy and safety of tralokinumab in the treatment of atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials. | Medicine (Baltimore) | 2023 | 37543792 | PubTator, text mining | PubMed |
| Transcriptome alterations in peripheral blood B cells of patients with multiple sclerosis receiving immune reconstitution therapy. | J Neuroinflammation | 2023 | 37533036 | PubTator, text mining | PubMed |
| Challenges and Future Trends in Atopic Dermatitis. | Int J Mol Sci | 2023 | 37511138 | PubTator, text mining | PubMed |
| Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging. | Biomedicines | 2023 | 37509725 | PubTator, text mining | PubMed |
| An Assessment of the Penile Squamous Cell Carcinoma Surfaceome for Biomarker and Therapeutic Target Discovery. | Cancers (Basel) | 2023 | 37509297 | PubTator, text mining | PubMed |
| Asymmetric dimerization in a transcription factor superfamily is promoted by allosteric interactions with DNA. | Nucleic Acids Res | 2023 | 37503845 | PubTator, text mining | PubMed |
| Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer. | Nat Cancer | 2023 | 37488416 | PubTator, text mining | PubMed |
| Identification of hub genes and therapeutic drugs in osteonecrosis of the femoral head through integrated bioinformatics analysis and literature mining. | Sci Rep | 2023 | 37488209 | PubTator, text mining | PubMed |
| Identification and characterisation of anti-IL-13 inhibitory single domain antibodies provides new insights into receptor selectivity and attractive opportunities for drug discovery. | Front Immunol | 2023 | 37483614 | PubTator, text mining | PubMed |
| Design of Glycoengineered IL-4 Antagonists Employing Chemical and Biosynthetic Glycosylation. | ACS Omega | 2023 | 37483220 | PubTator, text mining | PubMed |
| NOTCH4 potentiates the IL-13 induced genetic program in M2 alternative macrophages through the AP1 and IRF4-JMJD3 axis. | Int Immunol | 2023 | 37478314 | PubTator, text mining | PubMed |
| Identification of immune biomarkers in recent active pulmonary tuberculosis. | Sci Rep | 2023 | 37460564 | PubTator, text mining | PubMed |
| Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential. | Explor Target Antitumor Ther | 2023 | 37455828 | PubTator, text mining | PubMed |
| Aging modifies endometrial dendritic cell function and unconventional double negative T cells in the human genital mucosa. | Immun Ageing | 2023 | 37452337 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3597/papers?page=9